A matrix metalloproteinase inhibitor to treat unresectable cholangiocarcinoma
about
Raf kinase inhibitor protein inhibits cholangiocarcinoma cell metastasis by downregulating matrix metalloproteinase 9 and upregulating tissue inhibitor of metalloproteinase 4 expression.Variations in expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in nasal mucosa of aspirin-sensitive versus aspirin-tolerant patients with nasal polyposis.Molecular Markers in the Pathogenesis of Cholangiocarcinoma: Potential for Early Detection and Selection of Appropriate Treatment.
P2860
A matrix metalloproteinase inhibitor to treat unresectable cholangiocarcinoma
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
A matrix metalloproteinase inhibitor to treat unresectable cholangiocarcinoma
@ast
A matrix metalloproteinase inhibitor to treat unresectable cholangiocarcinoma
@en
type
label
A matrix metalloproteinase inhibitor to treat unresectable cholangiocarcinoma
@ast
A matrix metalloproteinase inhibitor to treat unresectable cholangiocarcinoma
@en
prefLabel
A matrix metalloproteinase inhibitor to treat unresectable cholangiocarcinoma
@ast
A matrix metalloproteinase inhibitor to treat unresectable cholangiocarcinoma
@en
P2093
P2860
P1476
A matrix metalloproteinase inhibitor to treat unresectable cholangiocarcinoma
@en
P2093
J J French
M J Midwinter
M K Bennett
R M Charnley
P2860
P304
P356
10.1080/13651820510042246A
P577
2005-01-01T00:00:00Z